Association of Caudal-Type Homeobox 2 Immunohistochemical Expression With Pathological Stage, Tumor Grade, and Histological Subtype in Colorectal Malignancies: A Single-Center Observational Study
Findings support CDX2 as a practical adjunct marker of adverse tumor biology in colorectal malignancies rather than independent survival prognostication and support clinicopathological prognostic association rather than independent survival prognostication.